"We are pleased this abstract was accepted for presentation at AASLD ... the ability to develop a commercially feasible technology and its dependence on third parties to design and manufacture its ...
Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...
Q3 2024 Earnings Call Transcript November 11, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.51, ...
New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...
Dyna.Ai, a Singaporean AI-as-a-Service company, took center stage at the 2024 Singapore Fintech Festival with the unveiling ...
Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...
New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology platform trigger targeted immune responses Results also showcase the successful design of a proprietary pref ...
Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback